✦ LIBER ✦

Pharmacokinetics (PK) of 2 dosing regimens of palifermin in patients (Pts) with hematologic malignancies (HM) undergoing high-dose chemoradiotherapy and hematopoietic stem cell transplantation (HSCT)

✍ Scribed by P. Zia-Amirhosseini; M. Salfi; D. Elhardt; J. Aycock; T.C. Cheah; A. Cesano; D.D. Hurd

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palifermin (a RHUKGF molecule) is safe a

✍ B.R. Blazar; D.J. Weisdorf; T.E. DeFor; A.I. Goldman; S. Silver; J.L.M. Ferrara 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

211: The significance of palifermin (Kep

✍ B. Nasilowska-Adamska; P. Rzepecki; J. Manko; A. Czyz; M. Markiewicz; I. Fedorow 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 73 KB

217: Evaluation of single-dose palifermi

✍ T. Shea; T. Kewalramani; Y. Mun; J. Jayne; L. Dreiling 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Identification of an AUC of 7603 Umol∗Mi

✍ W.A. Wood; C.M. Walko; K.V. Rao; J. Whitley; D.T. Moore; D.A. Gabriel; J.S. Sero 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB